Motiva Breast Augmentation

European CE certification / Korean Ministry of Food and Drug Safety authorization / ISO 13485 certification Motiva implants obtained GMP certification for safety and quality standards applying to manufacturing and imported medical products, and were approved for sale after Korean food and drug regulators inspected the manufacturing facilities on site. They also comply with EU requirements for safety, health, the environment, and consumer protection and hold comprehensive CE certification. Motiva is authorized by the Ministry of Food and Drug Safety, while its manufacturing facilities hold ISO 13485 certification and operate in a controlled environment. Motiva implant materials offer strong durability. The ergonomic silicone-gel shell combines precision and elasticity, allowing a smaller surgical incision. Motiva's viscoelastic silicone gel moves naturally under gravity: it forms a teardrop-like contour when standing and spreads naturally when lying down.

MOTIVA ERGONOMIX

The shell combines elasticity, which can reduce incision size, with precision that limits impact on surrounding tissue during placement. Made from silicone gel intended for long-term implantation and evaluated through FDA chemical, physical, and biological testing. Uses a specialized surface structure without foreign substances such as salt or sugar that could damage the implant shell. Morning surgery: discharge that afternoon. Afternoon surgery: one-night stay. High-performance shell 1.5 hours Properties of the silicone gel Surface treatment BluSeal® monitoring technology Barrier-layer technology allows the safety status of a Motiva implant to be checked within the Motiva Implant Matrix system. UDI Microtransponder The VeriTeQ UDI Microtransponder is a radio-frequency identification device (RFID) intended for use in the body and for identifying breast implants. Extended Warranty Aftercare is provided if rupture or grade III or IV capsular contracture occurs within five years after surgery. Procedure time Anesthesia General anesthesia Suture removal No suture removal required (medical tissue adhesive) Hospital stay

REAL ONE STOP CARE

Breast cancer screening and assessment for abnormalities Preoperative examination Patients who have not yet undergone breast cancer screening should be examined before surgery to confirm that there are no breast abnormalities. REAL places safety first, so this step is not omitted even though it adds complexity. Screening can be coordinated with the surgical schedule at a nearby partner hospital. Minimal dissection, trusted implants, and a highly specialized breast-surgery team The patient signs informed consent, fully reviews postoperative precautions, and consults the director again to confirm the surgical plan before proceeding. Surgery is performed under the direction of a senior plastic surgeon with more than ten years of breast-surgery experience, while a specialist anesthesia team monitors the entire procedure in real time. Postoperative recovery and hospital stay Care after discharge